Related Experiment Video

Updated: Jun 10, 2025

Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.0K

Nanoformulations of amphotericin B to resolve challenges in antifungal therapy

Manisha Patel1, Vineet K Jain2, Harvinder Popli2

  • 1Drug Delivery & Nanomedicine Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER)-Raebareli, Uttar Pradesh, 226002, India.

Nanomedicine (London, England)
|October 11, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
antifungalbioavailabilitycytotoxicityefficacyhemolytic toxicity

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.8K
Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

2.2K

Related Experiment Videos

Last Updated: Jun 10, 2025

Formulation and Characterization of Bioactive Agent Containing Nanodisks
07:58

Formulation and Characterization of Bioactive Agent Containing Nanodisks

Published on: March 17, 2023

1.0K
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

18.8K
Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

2.2K

Related Concept Videos

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

289
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
289

Articles linked to this work by shared authors, journal, and citation graph.

Lurasidone hydrochloride-loaded microparticle-based long-acting injectable: formulation optimisation, characterisation, and payload release kinetics-a proof of concept study.

Journal of microencapsulation·2026

Nose-to-Brain Delivery of Donepezil Hydrochloride via Oleic Acid-Conjugated PAMAM G4 Dendrimers for the Treatment of Alzheimer's-Like Dementia.

Molecular pharmaceutics·2025

Development and characterization of multifunctional dendrimeric nanoconjugates for delivery of rutin: in vitro characterization for potential neuroprotective application.

Nanomedicine (London, England)·2025

Formulation development, characterization, and evaluation of bedaquiline fumarate - Soluplus® - solid dispersion.

Pharmaceutical development and technology·2024

Novel ligand decorated theranostic zein nanoparticles coloaded with paclitaxel and carbon quantum dots: formulation and optimization.

Nanomedicine (London, England)·2024

Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies.

Stem cells international·2024

The Italian Nanomedicine Platform (INP): national integration within the European nanomedicine ecosystem.

Nanomedicine (London, England)·2026

Recent advances in the application of electrospun nanofibrous scaffolds in bone regeneration.

Nanomedicine (London, England)·2026

A novel rosiglitazone-phosphatidylserine composite nanoparticle mediated targeted drug delivery to macrophages for treatment of ulcerative colitis.

Nanomedicine (London, England)·2026

CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer.

Nanomedicine (London, England)·2026

Mucus-penetrating nanocarriers for the enhanced oral delivery of antibody drugs.

Nanomedicine (London, England)·2026

Fluorescently labeled Angiopep-2-conjugated-PAMAM nanoparticles to evaluate drug brain-targeted delivery performance.

Nanomedicine (London, England)·2026

A simulation of recreational and addictive methamphetamine use on the integrity of the blood-brain barrier endothelium using an in vitro BBB model.

Tissue barriers·2026

Feasibility and acceptability of smartphone-based ecological momentary assessment for monitoring suicidal ideation among gay, bisexual, and other men who have sex with men in Nepal.

Journal of mental health (Abingdon, England)·2026

IL-5/IL-5R blockade enables safe non-steroidal anti-inflammatory agent reintroduction in non-steroidal anti-inflammatory exacerbated respiratory disease.

Frontiers in immunology·2026

Case Report: Electrode perforation with normal pacemaker parameters leading to hemorrhagic shock: a rare case report of the "penetration-exit-re-entry" phenomenon.

Frontiers in medicine·2026

Assessment of drug harm by final-year medical students and ChatGPT - a comparative analysis.

Substance abuse treatment, prevention, and policy·2026

Import of antibiotics by air travellers - an observational study at airports in Sweden and Norway.

Antimicrobial resistance and infection control·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us